Tumor volume as a predictor of survival and local control in patients with brain metastases treated with Gamma Knife surgery

医学 多元分析 单变量分析 比例危险模型 脑转移 生存分析 脑瘤 内科学 肿瘤科 外科 核医学 放射科 癌症 转移 病理
作者
Andrew M. Baschnagel,Kurt Meyer,Peter Y. Chen,Daniel Krauss,R.E. Olson,Daniel Pieper,Ann Maitz,Hong Ye,Inga S. Grills
出处
期刊:Journal of Neurosurgery [American Association of Neurological Surgeons]
卷期号:119 (5): 1139-1144 被引量:201
标识
DOI:10.3171/2013.7.jns13431
摘要

OBJECT: The aim of this study was to examine tumor volume as a prognostic factor for patients with brain metastases treated with Gamma Knife surgery (GKS). METHODS: Two hundred fifty patients with 1-14 brain metastases who had initially undergone GKS alone at a single institution were retrospectively reviewed. Patients who received upfront whole brain radiation therapy were excluded. Survival times were estimated using the Kaplan-Meier method. Univariate and multivariate analyses using Cox proportional hazard regression models were used to determine if various prognostic factors could predict overall survival, distant brain failure, and local control. RESULTS: Median overall survival was 7.1 months and the 1-year local control rate was 91.5%. Median time to distant brain failure was 8.0 months. On univariate analysis an increasing total tumor volume was significantly associated with worse survival (p = 0.031) whereas the number of brain metastases, analyzed as a continuous variable, was not (p = 0.082). After adjusting for age, Karnofsky Performance Scale score, and extracranial disease on multivariate analysis, total tumor volume was found to be a better predictor of overall survival (p = 0.046) than number of brain metastases analyzed as a continuous variable (p = 0.098). A total tumor volume cutoff value of ≥ 2 cm(3) (p = 0.008) was a stronger predictor of overall survival than the number of brain metastases (p = 0.098). Larger tumor volume and extracranial disease, but not the number of brain metastases, were predictive of distant brain failure on multivariate analysis. Local tumor control at 1 year was 97% for lesions < 2 cm(3) compared with 75% for lesions ≥ 2 cm(3) (p < 0.001). CONCLUSIONS: After adjusting for other factors, a total brain metastasis volume was a strong and independent predictor for overall survival, distant brain failure, and local control, even when considering the number of metastases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zaphkiel完成签到,获得积分10
刚刚
Pepsi完成签到 ,获得积分10
刚刚
攒一口袋星星完成签到,获得积分20
1秒前
2秒前
宵暮夕完成签到,获得积分10
2秒前
Jason完成签到,获得积分10
2秒前
Jessy畅畅应助精明夏岚采纳,获得10
3秒前
LQ完成签到,获得积分10
5秒前
脑洞疼应助舍不得你采纳,获得10
6秒前
科研通AI6.2应助有点奔采纳,获得10
7秒前
8秒前
丘比特应助Hey采纳,获得10
9秒前
9秒前
9秒前
rikka完成签到,获得积分10
10秒前
四火完成签到,获得积分10
11秒前
yj完成签到,获得积分10
11秒前
zaphkiel发布了新的文献求助30
11秒前
科研通AI6.2应助Dean采纳,获得10
11秒前
满意问晴发布了新的文献求助10
11秒前
zhilingZhang完成签到,获得积分10
14秒前
Jasper应助tianshicanyi采纳,获得10
15秒前
15秒前
15秒前
挺萌的小龙虾完成签到,获得积分10
16秒前
谷粱安卉完成签到 ,获得积分10
17秒前
suy完成签到,获得积分10
17秒前
潇洒的诗桃应助裴裴采纳,获得30
17秒前
Firsterchao应助裴裴采纳,获得30
17秒前
Firsterchao应助裴裴采纳,获得30
18秒前
路豐遙应助裴裴采纳,获得30
18秒前
xuejingling应助裴裴采纳,获得30
18秒前
xuejingling应助裴裴采纳,获得30
18秒前
潇洒的诗桃应助裴裴采纳,获得10
18秒前
路豐遙应助裴裴采纳,获得10
18秒前
Firsterchao应助裴裴采纳,获得10
18秒前
xuejingling应助裴裴采纳,获得10
18秒前
负责戎完成签到,获得积分10
19秒前
星辰大海应助lxl采纳,获得10
21秒前
充电宝应助tianshicanyi采纳,获得10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Periodic Report Summary 2 - AFTER (A Framework for electrical power sysTems vulnerability identification, dEfense and Restoration) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7319278
求助须知:如何正确求助?哪些是违规求助? 8934998
关于积分的说明 18940585
捐赠科研通 6978018
什么是DOI,文献DOI怎么找? 3214386
关于科研通互助平台的介绍 2382246
邀请新用户注册赠送积分活动 2193354